Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 3;7(6):e2417094.
doi: 10.1001/jamanetworkopen.2024.17094.

Cervical Cancer Screening Rates Among Rural and Urban Females, From 2019 to 2022

Tyrone F Borders  1   2 , Amanda Thaxton Wiggins  2
Affiliations

Cervical Cancer Screening Rates Among Rural and Urban Females, From 2019 to 2022

Tyrone F Borders et al. JAMA Netw Open. .

Abstract

Importance: Little nationally representative research has examined Papanicolaou testing rates from before the pandemic in 2019 through the COVID-19 pandemic in 2022. Papanicolaou testing rates among rural females are a concern as they have historically had lower screening rates than their urban counterparts.

Objective: To examine the receipt of a Papanicolaou test in the past year among US females overall and females residing in rural and urban areas in 2019, 2020, and 2022.

Design, setting, and participants: This repeated cross-sectional study used data from 3 years of the Health Information National Trends Survey (HINTS), a nationally representative survey that asks respondents about cancer screenings, sources of health information, and health and health care technologies. Study participants were females aged 21 to 65 years. Individuals who received a Papanicolaou test more than 1 to 3 years prior to a HINTS interview were excluded as they were likely not due for a Papanicolaou test.

Exposures: Survey year (2019, 2020, and 2022) and rural or urban residence were the main exposure variables.

Main outcomes and measures: Self-reported receipt of a Papanicolaou test within the past year.

Results: Among the 188 243 531 (weighted; 3706 unweighted) females included in the analysis, 12.5% lived in rural areas and 87.5% in urban areas. Participants had a mean (SE) age of 43.7 (0.27) years and were of Hispanic (18.8%), non-Hispanic Asian (5.2%), non-Hispanic Black (12.2%), non-Hispanic White (59.6%), or non-Hispanic other (4.1%) race and ethnicity. In 2022, unadjusted past-year Papanicolaou testing rates were significantly lower among rural vs urban residents (48.6% [95% CI, 39.2%-58.1%] vs 64.0% [95% CI, 60.0%-68.0%]; P < .001). Adjusted odds of past-year Papanicolaou testing were lower in 2022 than 2019 (odds ratio, 0.70; 95% CI, 0.52-0.95; P = .02).

Conclusions and relevance: This repeated cross-sectional study found that past-year Papanicolaou testing rates were lower in 2022 than 2019, pointing to a need to increase access to screenings to prevent an uptick in cervical cancer incidence. Rural-vs-urban differences in 2022 indicate a need to specifically target rural females.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr. Borders reported receiving grants from the Health Resources and Services Administration (HRSA) during the conduct of the study. No other disclosures were reported.

Figures

Figure.
Figure.. Past-Year Papanicolaou Test by Geographic Residence Across Study Years
Error bars represent 95% CIs.
See this image and copyright information in PMC

References

    1. Fedewa SA, Star J, Bandi P, et al. . Changes in cancer screening in the US during the COVID-19 pandemic. JAMA Netw Open. 2022;5(6):e2215490. doi:10.1001/jamanetworkopen.2022.15490 - DOI - PMC - PubMed
    1. Wentzensen N, Clarke MA, Perkins RB. Impact of COVID-19 on cervical cancer screening: challenges and opportunities to improving resilience and reduce disparities. Prev Med. 2021;151:106596. doi:10.1016/j.ypmed.2021.106596 - DOI - PMC - PubMed
    1. Mast C, Munoz del Rio A. Delayed cancer screenings: a second look. 2020. Accessed April 8, 2024. https://epicresearchblob.blob.core.windows.net/cms-uploads/pdfs/Delayed-...
    1. DeGroff A, Miller J, Sharma K, et al. . COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States. Prev Med. 2021;151:106559. doi:10.1016/j.ypmed.2021.106559 - DOI - PMC - PubMed
    1. Moss JL, Liu B, Feuer EJ. Urban/rural differences in breast and cervical cancer incidence: the mediating roles of socioeconomic status and provider density. Womens Health Issues. 2017;27(6):683-691. doi:10.1016/j.whi.2017.09.008 - DOI - PMC - PubMed

Publication types

MeSH terms